Cameroon vs Djibouti: Pneumococcal conjugate second or third-dose vaccines (PCVc)
Cameroon
82.0%
in 2025
Djibouti
82.0%
in 2025
Cameroon rank
104th
Djibouti rank
104th
Pneumococcal conjugate second or third-dose vaccines (PCVc) over time
- Cameroon
- Djibouti
How they compare
Cameroon currently reports 82.0% against 82.0% in Djibouti, a difference of 0.0%.
The two have swapped places 6 times across 18 shared years of data; in 2008 it was Djibouti ahead.
Cameroon ranks 104th and Djibouti ranks 104th of 192 countries.
Cameroon has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Cameroon | Djibouti | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0.0% | 0.0% | 0.0% | — |
| 2010s | 62.2% | 55.5% | 6.7% | Cameroon |
| 2020s | 73.7% | 69.7% | 4.0% | Cameroon |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher pneumococcal conjugate second or third-dose vaccines (pcvc), Cameroon or Djibouti?
- Cameroon, at 82.0% against 82.0% in Djibouti as of 2025.
- What is the difference in pneumococcal conjugate second or third-dose vaccines (pcvc) between Cameroon and Djibouti?
- 0.0%, with Cameroon ahead.
- How many years of comparable data are there for Cameroon and Djibouti?
- 18 years are reported by both, from 2008 to 2025.
- How do Cameroon and Djibouti rank globally for pneumococcal conjugate second or third-dose vaccines (pcvc)?
- Cameroon ranks 104th and Djibouti ranks 104th of 192 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid refreshes it automatically from the source and publishes the full history for both places.